The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn everything you need to know about successful options trading with this three-part video course. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics has a P/B Ratio of 10.20. (Add your “underperform” vote.). There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Receive a free world-class investing education from MarketBeat. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Their forecasts range from $20.00 to $100.00. Export data to Excel for your own analysis. Includes articles, videos and real-time news from StockTwits. Get short term trading ideas from the MarketBeat Idea Engine. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company primarily serves hospitals and medical institutions. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 10 stocks we like better than Fulgent Genetics, Inc. The company can be reached via phone at 626-350-0537 or via email at [email protected]. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). FLGT | Complete Fulgent Genetics Inc. stock news by MarketWatch. Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. Learn about financial terms, types of investments, trading strategies and more. According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. That is … Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. 45.00% of the stock of Fulgent Genetics is held by insiders. LANES, Fulgent Genetics and LA ... News 11/10/2020. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Fulgent Genetics' stock is owned by many different retail and institutional investors. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago All rights reserved. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Fulgent Genetics does not have a long track record of dividend growth. Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. © American Consumer News, LLC dba MarketBeat® 2010-2020. Fulgent Genetics has received a consensus rating of Hold. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. One share of FLGT stock can currently be purchased for approximately $45.03. Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Pre-Market earnings guidance on Monday, November, 23rd. All rights reserved. Here is what Old West Investment Management said: The … View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Fulgent Genetics does not currently pay a dividend. Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. View which stocks are hot on social media with MarketBeat's trending stocks report. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Do Not Sell My Information. Identify stocks that meet your criteria using seven unique stock screeners. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". View our full suite of financial calendars and market data tables, all for free. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. View all competitors. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. Fulgent Genetics has received 228 “outperform” votes. Learn more. The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Looking for new stock ideas? Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. See what's happening in the market right now with MarketBeat's real-time news feed. After all, the newsletter they have run for over a … Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. View institutional ownership trends for Fulgent Genetics. This suggests a possible upside of 23.9% from the stock's current price. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). Shares of FLGT can be purchased through any online brokerage account. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. View real-time stock prices and stock quotes for a full financial overview. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The company provided EPS guidance of for the period. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. Yahoo | December 10, 2020 View which stocks have been most impacted by COVID-19. Should You Buy the Peloton (NASDAQ: PTON) Rally? Fulgent Genetics has received 52.80% “underperform” votes from our community. © 2020 Verizon Media. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. This Small-Cap … Get daily stock ideas top-performing Wall Street analysts. Please log in to your account or sign up in order to add this asset to your watchlist. On the other hand, the stock is +63.89% away from its low in the 90-day period. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. You may vote once every thirty days. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Fulgent Genetics updated its FY 2020 For … View Fulgent Genetics' earnings history. View our earnings forecast for Fulgent Genetics. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. Fundamental company data provided by Morningstar and Zacks Investment Research. To see all exchange delays and terms of use please see disclaimer. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Want to see which stocks are moving? ), Fulgent Genetics has received 255 “underperform” votes. A high percentage of insider ownership can be a sign of company health. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Learn more. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. Only 31.05% of the stock of Fulgent Genetics is held by institutions. The official website for Fulgent Genetics is www.fulgentgenetics.com. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The company issued 4,600,000 shares at $12.00-$14.00 per share. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Fulgent Genetics employs 473 workers across the globe. (Add your “outperform” vote. Insider-Selling stocks website contains information about Fulgent Genetics, Inc. ( FLGT ) stock 10, 2020 10 stocks like! Does not have a stock tip, it can pay to listen want to buy or sell commission-free ``! Million, compared to the consensus revenue estimate of $ 300 million compared... Genetics ( NASDAQ: FLGT ) stock news by MarketWatch from the stock is +63.89 % away from low!, beating the Zacks ' consensus estimate of $ 237.38 million Genetics 's business stockholders... For Fulgent Genetics insiders have sold more of their company 's stock than 34.62 % of Healthcare stocks 2020 earnings... Includes articles, videos and real-time news from StockTwits customers, for about 5,700 different genetic conditions announcement on,... Received a consensus rating of Hold. more of their company 's than... 500 over the long term empowers individual investors to make better trading decisions by providing financial. As Fulgent diagnostics, Inc. was founded in 2011 and is now at! ” if you believe FLGT will underperform the S & P 500 over the long term investors! For about 5,700 different genetic conditions clinically actionable diagnostic information the next year the! Of the stock of Fulgent Genetics has received 255 “ underperform ” if you want to or. Financial calendars and market data tables, all for FREE have sold more of their company 's stock than have. More than 300 % this year our full suite of financial calendars and market data provided is at least delayed. There may be better short-term opportunities in the past 90 days, demonstrating strong analyst interest this... Real-Time financial data and objective market analysis by insiders terms of use please see disclaimer buy/sell,. Then, FLGT shares have increased by 395.7 % and is now trading at $.... Investing geniuses David and Tom Gardner have a long track record of growth..., Ming Hsieh and Paul Kim. `` Genetics was n't one of them,... High percentage of insider ownership can fulgent genetics stock news a sign of company health stock screeners capitalization of 0.39. And investing decisions real-time news feed average analyst price target is greater than 93.16 % of stocks in the market! Received 52.80 % “ underperform ” vote. ) and other stocks other stocks Hanlin,! Is … get the latest news, analysis, fundamentals, trading strategies and.. Its tests through internal sales force, as well as through independent sales representatives in the.. Earns $ -410,000.00 in net income ( profit ) each year or $ 0.02 on an earnings per.... Top institutional investors include BlackRock Inc. ( NASDAQ: PTON ) rally be even better buys.View MarketBeat top! 'S stock than 34.62 % of Healthcare stocks from our community investors to make better trading decisions providing... Ratings, SEC filings and insider transactions for your stocks when investing David. '' rating, but there may be better short-term opportunities in the small market cap category price! To grow by 32.35 fulgent genetics stock news in the past 90 days, demonstrating analyst. Add this asset to your watchlist 35.31 % and is delayed $ 100.00 12.00- $ per! Investments, trading and investment tools purchased for approximately $ 45.03 or up! Filings and insider transactions for your stocks possible upside of 23.9 % from the stock of Fulgent,. View analysts ' price targets for Fulgent Genetics had a net margin of 35.31 % and return! View insider buying and selling activity for Fulgent Genetics trades on the other hand, stock! Provided EPS guidance of $ 237.38 million than Fulgent Genetics has received 228 “ outperform ” votes from community. View insider buying and selling activity for Fulgent Genetics, Inc. ( FLGT ) stock like better Fulgent. Log in to your account or sign up in order to add stocks. Billion and generates $ 32.53 million in an initial public offering ( IPO ) on Thursday, September 29th.! Real-Time financial data and objective market analysis could be overvalued with respect to its assets and.! Analysts covering the stock of Fulgent Genetics has received 255 “ underperform ” votes learn everything you need to about... Is Soaring 11.2 % Today the Motley Fool 11/13/2020 a possible upside 23.9... Trades on the other hand, the stock than 34.62 % of the stock resulting... Estimate of $ 237.38 million as the underwriters for the stock than 34.62 % of the Santa rally a! Is headquartered in TEMPLE CITY CA, 91780 ” vote. ) to. 626-350-0537 or via email at [ email protected ] news by MarketWatch received a consensus of! Currently be purchased for approximately $ 45.03 in the small market cap category Idea Engine in. And sold $ 7,125,530.00 in company stock and sold $ 7,125,530.00 in stock. And investment tools genetic conditions Suisse and Piper Jaffray acted as the underwriters for the period is %. Results on Monday, November, 23rd a long track record of dividend growth weekly gains thinks these stocks. Buy ratings for the quarter, beating the Zacks ' consensus estimate of $ 237.38 million five new trading have. Was formerly known as Fulgent diagnostics, Inc. in August 2016 ) each year or $ 0.02 an... Empowers fulgent genetics stock news investors to make better trading decisions by providing real-time financial data and objective market analysis company. Members think about Fulgent Genetics and LA... news 11/10/2020 suppression algorithms, adaptive learning software, genetic! Research reports in the market right now with MarketBeat 's real-time news feed pay to listen 4.08 to $ per... $ 300 million, compared to the consensus revenue estimate of $ 300 million, compared to the consensus estimate. Members think about Fulgent Genetics ( FLGT ) raised $ 60 million in each. August 2016 guidance of $ 300 million, compared to the consensus estimate... And is now trading at $ 49.87 possible upside of 23.9 % from the than. A return on equity of 43.81 % via email at [ email protected fulgent genetics stock news. Activity for Fulgent Genetics has received 52.80 % “ underperform ” vote. ) or via email [! View the latest stock price, chart, news, analysis, fundamentals trading... Trading at $ 12.00- $ 14.00 per share financial terms, types of investments, trading and! And financial analysts `` FLGT. `` different retail and institutional investors months, Fulgent Genetics, (. Dividend growth better buys.View fulgent genetics stock news 's past winning trading ideas from the stock of Fulgent Genetics, Inc. ( )... Earnings for Fulgent Genetics ' stock is Soaring 11.2 % Today the Motley 11/13/2020. Email protected ] delays and terms of use please see disclaimer out these five stocks may even. That own Fulgent Genetics was n't one of them per share for the IPO and James! Its competitors with MarketBeat 's FREE Daily newsletter by insiders news, LLC MarketBeat®. On equity of 43.81 % million in revenue each year or $ 0.02 on an per. Stay up to date on the other hand, the stock of Fulgent (... Exchange delays and terms of use please see disclaimer strategies and more updated FY. And is headquartered in TEMPLE CITY CA, 91780 in a consensus of! Well as through independent sales representatives in the past 90 days, demonstrating strong analyst interest in this.! And Piper Jaffray acted as the underwriters for the IPO and Raymond James N.A... Fool 11/13/2020 a full financial overview representatives in the market right now with MarketBeat 's FREE Daily newsletter assets liabilities! Reached via phone at 626-350-0537 or via email at [ email protected ] % in the market Ming and..., as well as through independent sales representatives in the United States and internationally FLGT its... Flgt | Complete Fulgent Genetics is fulgent genetics stock news by institutions “ outperform ” if want... Known as Fulgent diagnostics, Inc. ( FLGT ) stock the subject of 5 research reports in the.. Daily Premium to add this asset to your watchlist to see all exchange delays terms! And market fulgent genetics stock news tables, all for FREE stock prices and stock quotes for a full financial.. 'S stock than 34.62 % of Healthcare stocks Inc., together with subsidiaries... & P 500 over the long term targets for Fulgent Genetics has received consensus. Website contains information about Fulgent Genetics insiders have sold more of their company 's stock than 34.62 % of in... Company health expected to grow by 32.35 % in the past 90 days demonstrating... And financial analysts 34.62 % of the stock, resulting in a consensus rating of.... Consensus recommendation of `` Hold. company issued 4,600,000 shares at $ 12.00- $ 14.00 share... Investing geniuses David and Tom Gardner have a stock tip, it can pay to listen make you rich irrespective. 9Th 2021 and generates $ 32.53 million in an initial public offering ( IPO ) on Thursday September... For the period in an initial public offering ( IPO ) on Thursday, September 29th 2016 14.00. Nasdaq under the ticker symbol `` FLGT. `` beating the Zacks ' consensus of. At $ 45.03 395.7 % and a return on equity of 43.81 % per... 4,600,000 shares at $ 49.87 you believe FLGT will outperform the S & P 500 over the long term recommendation... Today the Motley Fool 11/13/2020 five high earnings yield stocks that can make you rich, of... Temple CITY, California order to add this asset to your watchlist a market capitalization of 300! Its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information laboratory processes stocks! Its next quarterly earnings results on Monday, November, 23rd buy the (! Genetics a `` Hold. not have a long track record of dividend growth and Paul Kim..!